Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 28 June 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Prevalence of eosinophilic esophagitis in the United States 

The latest issue of the Clinical Gastroenterology & Hepatology reports on the prevalence of eosinophilic esophagitis in the United States.

News image

Eosinophilic esophagitis has become a major cause of upper gastrointestinal morbidity in children and adults.

However, there are few data on the nationwide prevalence of eosinophilic esophagitis.

Dr Evan Dellon and colleagues from North Carolina, USA estimated the prevalence of eosinophilic esophagitis in the United States.

The research team collected health insurance claims from a large database that represented the U.S. commercially insured population.

The team analyzed data from 2008 to 2011, identifying cases of eosinophilic esophagitis by using a previously validated definition, and calculated a period prevalence by using data from 2009 to 2011.

Eosinophilic esophagitis was defined as any instance of the International Classification of Diseases, 9th revision code 530.13.

The estimated period prevalence of eosinophilic esophagitis was 57 per 100,000 persons
Clinical Gastroenterology & Hepatology

The team calculated the prevalence of the code in the database and standardized the estimate to the U.S. population.

Of 35,575,388 individuals in this database, 16,405 had at least 1 code for eosinophilic esophagitis.

The mean age was 34 years, 65% were male, 56% had dysphagia, and 53% had a diagnostic code for at least 1 allergic condition.

Among 11,569,217 individuals with continuous insurance coverage between mid-2009 and mid-2011, 6513 had at least 1 code for eosinophilic esophagitis.

When standardized to the U.S. population, the estimated period prevalence of eosinophilic esophagitis was 57 per 100,000 persons, translating to approximately 152,152 cases in the U.S.

The team observed that prevalence peaked in men 35–39 years old, with a rate of 115 per 100,000 persons.

Dr Dellon's team concludes, "Despite its relatively recent description, eosinophilic esophagitis is frequently diagnosed in the United States, with an estimated prevalence of 57 per 100,000 persons."

"This estimate depends on the accuracy of the International Classification of Diseases, 9th revision code, but it could be an underestimate, because knowledge of the code and recognition of eosinophilic esophagitis are increasing."

Clin Gastroenterol Hepatol 2014: 12(4): 589-596.e1
21 March 2014

Go to top of page Email this page Email this page to a colleague

 28 June 2016 
Cancer recurrence after immune-suppressive therapies
 28 June 2016 
Acute severe ulcerative colitis
 28 June 2016 
Gastric cancer screening in the USA
 27 June 2016 
Epidemiology of NAFLD
 27 June 2016 
Tobacco smoking and ulcerative colitis
 27 June 2016 
The Toronto Consensus for H. pylori treatment
 24 June 2016 
Fibre for chronic idiopathic constipation
 24 June 2016 
Dietary trends in the USA
 24 June 2016 
Statins and colorectal cancer in IBD
 23 June 2016 
Adverse events after colonoscopy bowel preparations
 23 June 2016 
Touch screens in the IBD outpatient clinic
 23 June 2016 
Biomarker for eosinophilic esophagitis diagnosis
 22 June 2016 
IBS symptoms in IBD
 22 June 2016 
Benefits and harms of colorectal cancer screening
 22 June 2016 
Outcomes among US veterans with Hep B
 21 June 2016 
Screening for colorectal cancer
 21 June 2016 
Tenofovir and Hep B transmission in mothers
 21 June 2016 
Access to liver subspecialty care and survival
 20 June 2016 
Genes for colorectal cancer risk
 20 June 2016 
Patients and gastroenterologists’ perceptions on IBD
 20 June 2016 
Hep C treatment in people who inject drugs
 17 June 2016 
Noninvasive markers of liver fibrosis
 17 June 2016 
Predictors of starting with long-term PPIs
 17 June 2016 
Extrahepatic manifestations of Hep C
 16 June 2016 
Endotracheal intubation and endoscopy unit efficiency metrics
 16 June 2016 
Assessing progression of NAFLD
 16 June 2016 
Bile acid diarrhea
 15 June 2016 
Consensus for acute severe ulcerative colitis
 15 June 2016 
Dental erosions in GERD
 15 June 2016 
Pharmacological treatments for obesity with weight loss
 14 June 2016 
Antibiotics and gut inflammation
 14 June 2016 
Liver-related mortality in the developed world
 14 June 2016 
Hep C patient outcomes treated with different anti-viral regimens
 13 June 2016 
Obesity in the USA
 13 June 2016 
Celiac disease drug development
 13 June 2016 
Pneumonia risk in celiac disease
 10 June 2016 

Celiac disease drug development

 10 June 2016 
Rectal cancer surgery checklist
 10 June 2016 
Breath as a marker for IBS
 09 June 2016 
Psychological morbidity in young people with IBD
 09 June 2016 
Predicting hepatic encephalopathy in cirrhosis
 09 June 2016 
Evaluation of endoscopic findings from patients with Crohn's
 08 June 2016 
Adult obesity trends in the USA
 08 June 2016 
Pediatric IBD unclassified vs other IBD
 08 June 2016 
Dark chocolate and NASH oxidation
 07 June 2016 
Flexible endoscopy for Zenker's diverticulum
 07 June 2016 
Predicting risk of hepatic encephalopathy in cirrhosis
 07 June 2016 
Electronic learning system for colon capsule endoscopy
 06 June 2016 
Disturbed sleep and symptoms in IBS
 06 June 2016 
Oral contraceptives and Crohn’s complications
 06 June 2016 
Eosinophilic esophagitis
 03 June 2016 
Antibiotic prophylaxis in cirrhosis
 03 June 2016 
Mortality in hospitalized peptic ulcer patients
 03 June 2016 
Decision aid for surgical patients with ulcerative colitis
 02 June 2016 
Allergy tests for eosinophilic esophagitis
 02 June 2016 
Fatty liver disease and mortality
 02 June 2016 
Ethnic inequalities in rectal cancer care
 01 June 2016 
Predicting NASH resolution
 01 June 2016 
Predicting relapse in IBD
 01 June 2016 
Treatment of Hep C/HIV after liver transplant

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us